These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24921061)

  • 1. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.
    Vandrey R; Johnson MW; Johnson PS; Khalil MA
    Adolesc Psychiatry (Hilversum); 2013 Apr; 3(2):123-134. PubMed ID: 24921061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?
    Ayres TC; Bond JW
    BMJ Open; 2012; 2(4):. PubMed ID: 22855623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.
    Rosenbaum CD; Carreiro SP; Babu KM
    J Med Toxicol; 2012 Mar; 8(1):15-32. PubMed ID: 22271566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs of abuse: clinical and legal considerations.
    Aoun EG; Christopher PP; Ingraham JW
    R I Med J (2013); 2014 Jun; 97(6):41-5. PubMed ID: 24905374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G; Hurst D; Penn A; Yung K
    Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.
    Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S
    Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
    Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
    Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
    Spiller HA; Ryan ML; Weston RG; Jansen J
    Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatric and addictologic complications of new synthetic products].
    Karila L; Benyamina A
    Rev Prat; 2018 Jun; 68(6):676-679. PubMed ID: 30869264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.
    Evans-Brown M; Sedefov R
    Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
    German CL; Fleckenstein AE; Hanson GR
    Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.